Geographic disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study by Ricci, Stephanie et al.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Obstetrics and Gynecology Faculty Publications Obstetrics and Gynecology
11-2017
Geographic disparities in the distribution of the







See next page for additional authors
Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_obgyn_facpubs
Part of the Neoplasms Commons, Obstetrics and Gynecology Commons, and the Oncology
Commons
This Journal Article is brought to you for free and open access by the Obstetrics and Gynecology at Health Sciences Research Commons. It has been
accepted for inclusion in Obstetrics and Gynecology Faculty Publications by an authorized administrator of Health Sciences Research Commons. For
more information, please contact hsrc@gwu.edu.
APA Citation
Ricci, S., Tergas, A., Roche, K., Fairbairn, M., Levinson, K., Lopez-Acevedo, M., & +several additional authors (2017). Geographic
disparities in the distribution of the U.S. gynecologic oncology workforce: A Society of Gynecologic Oncology study. Gynecologic
Oncology Reports, (). http://dx.doi.org/10.1016/j.gore.2017.11.006
Authors
Stephanie Ricci, Ana Tergas, Kara Roche, Melissa Fairbairn, Kimberly Levinson, Micael Lopez-Acevedo, and
+several additional authors
This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/smhs_obgyn_facpubs/188




Geographic disparities in the distribution of the U.S. gynecologic oncology
workforce: A Society of Gynecologic Oncology study
Stephanie Riccia,b, Ana I. Tergasc, Kara Long Roched, Melissa Gerardi Fairbairna,g,
Kimberly L. Levinsona,g, Sean C. Dowdye,g, Robert E. Bristowf,g, Micael Lopezh,g,
Katrina Slaughteri,g, Kathleen Moorei,g, Amanda N. Fadera,⁎
a The Kelly Gynecologic Oncology Service, Department of Gynecology and Obstetrics, Johns Hopkins Medicine, Baltimore, MD, USA
bDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH, USA
c Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University School of Medicine, New York City, NY, USA
d Department of Gynecologic Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
e Division of Gynecologic Oncology, Department of Gynecology, Mayo Medical Center, Rochester, MN, USA
fDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of California, Irvine, Orange, CA, USA
g Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Virginia, Charlottesville, VA, USA
hDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, George Washington University, Washington, DC, USA
i Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The University of Oklahoma, Oklahoma City, OK, USA




A B S T R A C T
A recent ASCO workforce study projects a significant shortage of oncologists in the U.S. by 2020, especially in
rural/underserved (R/US) areas. The current study aim was to determine the patterns of distribution of U.S.
gynecologic oncologists (GO) and to identify provider-based attitudes and barriers that may prevent GOs from
practicing in R/US regions. U.S. GOs (n = 743) were electronically solicited to participate in an on-line survey
regarding geographic distribution and participation in outreach care. A total of 320 GOs (43%) responded;
median age range was 35–45 years and 57% were male. Most practiced in an urban setting (72%) at a university
hospital (43%). Only 13% of GOs practiced in an area with a population < 50,000. A desire to remain in
academics and exposure to senior-level mentorship were the factors most influencing initial practice location.
Approximately 50% believed geographic disparities exist in GO workforce distribution that pose access barriers
to care; however, 39% “strongly agreed” that cancer patients who live in R/US regions should travel to urban
cancer centers to receive care within a center of excellence model. GOs who practice within 50 miles of only 0–5
other GOs were more likely to provide R/US care compared to those practicing within 50 miles of ≥10 GOs
(p < 0.0001). Most (39%) believed the major barriers to providing cancer care in R/US areas were volume and
systems-based. Most also believed the best solution was a hybrid approach, with coordination of local and
centralized cancer care services. Among GOs, a self-reported rural-urban disparity exists in the density of gy-
necologic oncologists. These study findings may help address barriers to providing cancer care in R/US practice
environments.
1. Introduction
Multiple studies document a survival advantage for women with
gynecologic malignancies when treated by a gynecologic oncologist
(Earle et al., 2006; Chan et al., 2007, 2011). However, gynecologic
cancer patients require highly specialized care throughout the spectrum
of their lives, and this is not always available at suburban community
hospitals or rural medical centers. Prior reports suggest that distance
from residence to a gynecologic cancer treatment facility is a significant
barrier to care and may have a substantial impact on cancer outcomes
(Birkmeyer et al., 2004).
Although progress has occurred in the treatment and survival of
women with gynecologic malignancies, significant health care dis-
parities remain that prevent equal access to care. An unequal cancer
burden is borne by blacks, by individuals of lower socioeconomic
status, by the elderly and by those who are geographically remote from
a high volume cancer center with specialists (Mullee et al., 2004;
Karjalainen, 1990; Erikson et al., 2007; Braun and Clarke, 2006).
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Reports on survival disparities in other cancers, such as breast and
colorectal cancer, are attributed to differences in regionally-based so-
cioeconomic factors and to differences in access to and receipt of
quality treatment and post treatment follow-up (Karjalainen, 1990).
Geographic disparities in cancer survival are observed in several
studies (Karjalainen, 1990; Erikson et al., 2007; Gunderson et al., 2013;
Ward et al., 2004). Knowing whether cancer incidence and survival
vary geographically is important because health care is most often
delivered locally (Erikson et al., 2007). Therefore, identification of
areas with better or worse survival may reflect access to, and quality of,
care. Accordingly, understanding how location of cancer specialists
influences survival outcomes for those with cancer is critical. Yet, little
is known with respect to census data or distance-to-provider statistics of
the gynecologic oncology work force in particular. Therefore, the pri-
mary study aim was to define how the U.S. gynecologic oncology work
force is distributed geographically as well as to understand provider
practice patterns and attitudes with respect to outreach and providing
cancer care in rural settings. A secondary aim was determining survey
respondent opinions regarding potential solutions to cancer care access
issues, including adoption of dispersive care models compared with
centralized cancer care in urban “centers of excellence”.
2. Materials and methods
The study was conducted on behalf of the Society of Gynecologic
Oncology's Gynecologic Oncology (SGO) Fellows Research Network.
Institutional review board approval to conduct this study was obtained
through Johns Hopkins Hospital and Greater Baltimore Medical Center,
Baltimore, MD. An electronic survey study was performed and U.S.
gynecologic oncologists were invited to participate. After submitting an
application to the SGO, a list of SGO members' email addresses was
obtained. An email invitation to participate was sent out to all actively-
practicing, U.S. SGO members who are gynecologic oncologists
(n = 743). Those members who did not immediately complete the
survey were sent two additional email invitations to participate.
Participation was voluntary and was incentivized with a $15 Amazon
gift card, offered to each survey respondent upon completion of the
questionnaire.
The online, 40-item survey assessed provider demographics and
education, practice characteristics and geographic location and opi-
nions and practices regarding outreach. Most questions were designed
in multiple-choice or Likert formats; however respondents were also
given the opportunity to provide open-ended feedback on select ques-
tions. The responses of those who elected to provide written feedback
were subjected to qualitative analysis as described below. Descriptive
statistics were calculated with the number of responses as the de-
nominator. Fisher's exact test and the Chi-square test were used to de-
tect differences in responses among groups using Stata 11.1 statistical
software (StataCorp, College Town, TX).
2.1. Qualitative analysis
We conducted a thematic analysis aimed at identifying a set of main
themes in the views expressed (Silverman, 2000; Kumpulainen et al.,
2002). Using the open-ended responses provided by survey respondents
(n = 44), investigators SR and KLR read and discussed the content and
identified the main themes, which formed the basis of a draft-coding
framework. Both investigators then independently reviewed responses
applying the draft coding framework and making modifications to it
through an inductive and iterative process. The two investigators then
discussed the coding framework and coding choices in detail. Differ-
ences were resolved by consensus. All coding was reviewed in light of
these inter-reviewer discussions and decisions about the final frame-
work.
3. Results
A total of 320 (43%) gynecologic oncologists responded to the
survey. Compared to those who responded, non-respondents were more
likely to be older (> 65; p = 0.01) and more likely to practice in New
England (p = 0.02) or the West (p = 0.05). Provider demographics are
listed in Table 1. The median age range of respondents was 35–45 years
(42.7%), 57.0% were male, 83.9% were Caucasian and 85.7% were
married. Most respondents reported working> 20 years (28.1%) and
the majority practiced in an urban setting (73.2%), and at a university
hospital (40.5%). Most gynecologic oncologists reported practicing at
2–3 hospitals (48.0%) and practiced in multiple hospital systems
(67.2%). Services provided by gynecologic oncologists at ancillary
hospitals included surgery (93.6%), inpatient consultation (86.7%) and
outpatient clinical services (58.5%). Travel distance to ancillary hos-
pitals was estimated to be< 50 miles in most cases (86.4%), with only
13.6% of gynecologist oncologists traveling> 50 miles. Physicians in
academic practices were the least likely to serve in rural areas (6.5%),
while those at community hospitals were the most likely to serve rural
populations (22.1%; p = 0.006). Gynecologic oncologists who prac-
ticed at more than one hospital were not more likely to work in rural
areas (p = 0.19). Respondents estimated that approximately 1/3 of
patients live beyond 50 miles of their practice location and that 20–30%
of their patients had Medicaid or no insurance coverage.
The majority of respondents reported not performing outreach
(59.0%) because it was not an option in their current practice (52.8%)
or because their clinical workloads did not allow them to do so (53.2%).


















New England 26 8.15









Both Urban and Suburban 28 8.83
Both Urban and Rural 21 6.62
Both Suburban and Rural 7 2.21
Practice type
Federal government 8 2.61
University Hospital 133 43.46
Community Hospital 83 27.12
Hybrid 56 18.30
Solo private practice 3 0.98
Group private practice 37 12.09
Years in practice
3 years or less 59 18.59
4–9 years 79 24.92
10–20 years 90 28.39
> 20 years 89 28.08
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Table 2.> 42% practiced within 50 miles of 10 or more gynecologic
oncologists. Approximately 39% of respondents agreed that women
with a gynecologic cancer diagnosis who live in rural or underserved
regions should be expected to travel to urban cancer centers to receive
care; most (43.7%) of gynecologic oncologists believed it was reason-
able for women to travel 25–50 miles for care; while 41.7% believed
that 51–150 miles was reasonable.
There were a significantly greater number of gynecologic oncolo-
gists in New England and the Mid-Atlantic regions who practiced within
50 miles of 10 or more oncologists (68.2% and 66.7% respectively,
p < 0.0001). Furthermore, almost half (49.2%) of physicians at aca-
demic institutions reported practicing within 50 miles of 10 or more
oncologists (p = 0.05). Gynecologic oncologists who practiced within
50 miles of only 0–5 other oncologists were more likely to provide
outreach to rural areas compared to those who practiced within
50 miles of 10 or more oncologists (56.2% vs 31.7%, p < 00001). The
number of years in practice was not associated with outreach care
(p = 0.4). When examining patterns of practice by region, the West had
the greatest percentage of gynecologic oncologists providing outreach
(57.4%) compared to other regions (25.9 to 43.9%; p = 0.03).
3.1. Qualitative data analysis
Participants were given the opportunity to comment on strategies to
provide gynecologic cancer care for women living in areas remote from
comprehensive cancer centers. Of the 320 respondents, 58 (18%) pro-
vided feedback, which was analyzed using thematic interpretation as
described in the methods. There were three major themes identified:
quality care and safety, characteristics of both rural and centralized
gynecologic oncology care, and the need for coordination of centralized
and local services.
Thirty nine percent believed there were barriers to provision of
quality cancer care in rural or underserved areas; the majority (29.5%)
expressed the major impediment was systems-based (ie, lack of ICU,
other surgical services, ancillary staff). Survey respondents expressed
concern regarding the ability of smaller community hospitals to provide
comprehensive care for gynecologic oncology patients.
Throughout the responses, the issue of post-operative safety re-
curred. The concept of operating on a patient without personally
overseeing the post-operative care was felt to be dangerous and irre-
sponsible. Furthermore, ancillary services available at larger centers
were deemed necessary for patients undergoing lengthy surgeries re-
quiring multi-organ resection. Similarly, rural gynecologic oncology
care was characterized as low volume with limited support services. In
addition, it was felt that a model of localized care might place an un-
sustainable workload burden on gynecologic oncologists. Centralized
gynecologic oncology care was described in terms of high volume
centers with the infrastructure, expertise and ancillary support services
necessary for excellent patient care. The respondents highlighted the
importance of a multidisciplinary team approach to gynecologic cancer
care and what they viewed as directly correlating with optimizing pa-
tient outcomes.
An overwhelming majority of respondents believed the best solution
was for coordination of local and centralized services. This model
would necessitate patient travel for high complexity components of
care, but would allow for local access to care when the therapy interval
is required to be both lengthy and more frequent.
4. Discussion
A 2007 American Society of Clinical Oncology (ASCO) Work Force
study reports that the demand for visits to oncologists is expected to
increase approximately 50% by 2020, while supply will rise by only
14% (Kumpulainen et al., 2002; Gunderson et al., 2013). The projected
rise in demand for oncologists is largely driven by the doubling of the
number of Americans older than age 65 and an 80% increase in people
diagnosed with, or surviving, cancer. This translates to a shortfall of
between 2550 and 4080 oncologists overall. Due to lack of specific
demographic information for U.S. oncologists and their practices, it is
not possible to comprehend how prevalent access issues are in specific
geographic areas (Erikson et al., 2007). Additionally, there was little
emphasis on how these projections may impact gynecologic cancer
care.
Cancer care requires specialty surgical and medical resources that
may not consistently be found in rural areas. Oncology specialists in
particular are not found in abundance in rural settings, as their work
often requires tertiary hospital settings, found primarily in urban and
suburban regions with sizeable populations (Erikson et al., 2007;
Gunderson et al., 2013; Ward et al., 2004). Of the SGO members sur-
veyed in the current study, fewer than 13% reported working in rural
areas, especially those in academic appointments or residing in the Mid-
Atlantic and North East. Though many gynecologic oncologists prac-
ticed at more than one hospital, respondents reported these ancillary
institutions were commonly within 50 miles of their primary institu-
tion, with few reporting delivery of outreach rural or underserved re-
gions.
The most common concerns expressed by survey respondents re-
garding practicing in rural regions were: 1) low perceived clinical vo-
lumes, and 2) potential lack of access to multidisciplinary, systems-
based resources. The care of a gynecologic oncology patient is re-
cognizably complex and respondents opined that a multidisciplinary
approach to their care performed by high volume providers was crucial
for better survival outcomes. These are legitimate concerns, with
Wright et al. recently demonstrating that low volume hospitals may not
necessarily have higher surgical complication rates, but instead, may
demonstrate increased mortality rates (the concept of “failure to
rescue”) in those patients who do experience complications because of
lack of resources or medical expertise (Wright et al., 2012). Although
the majority of respondents agreed that significant distance-to-provider
disparities exist for gynecologic oncology patients and that these bar-
riers may impact the quality of care delivered, they overwhelmingly
expressed a need for centralization of the more complex aspects of
patient care at large, high volume “centers of excellence”, as demon-
strated by many European countries who employ this model of resource
Table 2
The most common factors preventing gynecologic oncologists from providing outreach or rural cancer care.
Answer choices % of respondents who answered affirmatively to each
question
N
I do not perceive a need for outreach in my current practice location 21.8 37
I do not have the transportation means to perform outreach 2.9 5
I am not interested in performing outreach 10 17
It is not an option to perform outreach in my current position 52.8 90
Existing payer pressures (ie changes in Medicare/Medicaid rules and reimbursement rates) prevent me from
considering outreach
7.7 13
The costs of running a practice prevent me from performing outreach 13.5 23
My clinical workload at my primary practice location is all-consuming 53.5 91
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allocation (Karjalainen, 1990; Erikson et al., 2007).
It is possible, though, that many living in rural America may not
have the means or the desire to travel to or receive care from a com-
prehensive cancer center or “center of excellence”. Whatever the rea-
sons, many rural cancer patients do not routinely receive guideline-
adherent cancer care by specialists (Earle et al., 2006; Karjalainen,
1990; Erikson et al., 2007; Braun and Clarke, 2006; Silverman, 2000),
and almost half of women with a gynecologic cancer in the U.S. are
receiving treatment at low volume hospitals or at centers poorly
equipped to provide the standard of care (Earle et al., 2006; Chan et al.,
2007, 2011). Further, despite the documented survival advantage for
women when treated by a gynecologic oncologist, women residing in
rural or underserved regions are not likely to receive care from a gy-
necologic specialist. Accordingly, how can this dilemma be reconciled?
A possible solution most likely lies in a hybrid centralized-dispersive
model. Surgical oncology services, which require the highest con-
centration of surgical/medical subspecialists, ancillary staff and un-
ique/costly facilities, are best performed at high volume hospitals or
cancer “centers of excellence”. Treatment delivered over a period of
time, such as routine chemotherapy and/or radiation treatments and
surveillance and survivorship care may be coordinated locally, with
experienced regional providers and specialists and with midlevel pro-
viders. Several survey respondents supported this hybrid model, as it
minimizes frequent long-distance travel while potentially granting rural
or underserved patients broader access to standard of care or novel
therapies. Development of national or state-specific policies to in-
centivize oncology fellowship graduates to work in underserved areas,
similar to the National Health Service Corps, may help alleviate this
problem.
Study strengths include the relatively high rate of survey responses
(43% response rate, when historically, the SGO membership population
has less than a 30% survey response rate (Worley et al., 2013; Garg
et al., 2011)), the geographic and practice-diversity of respondents and
obtaining pilot survey data that informs our understanding of the gy-
necologic oncology work force distribution in the U.S. Although we
could not test the validity of the open-ended responses, we observed
substantial internal consistency in views and themes across responses.
Limitations included the possibility of recall and selection bias among
respondents.
Our gynecologic oncology workforce study demonstrates that
among SGO members surveyed, a rural-urban disparity exists in the
density of gynecologic oncologists. It is possible this inequality may
affect patient access to cancer care services and may negatively influ-
ence outcomes for those with gynecologic cancer in rural areas.
However, our analysis was not designed to answer this question. Future
studies examining the impact of rurality status on clinical and survival
outcomes and whether it varies with geographic location are forth-
coming. It is our hope that these studies will inform providers, health
care systems, and policy makers as they work to ensure access to op-
timal cancer care services for rural populations.
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Appendix A. Appendix: select respondent answers to open-ended
questions regarding barriers to provision of gynecologic oncology
care in rural areas
A.1. Quality care and safety
“A major problem for gyn[ecologic] oncology surgery is that it
cannot be safely provided in all hospital settings, particularly for
ovarian cancer patients.”
“I think the major barrier to outreach is the services available at
hospitals in remote locations. For big oncologic cases, patients need to
be in places where the other multiple specialties are available (ICU,
good anesthesia, nurses with expertise in sick patients, etc). In addition,
the model of operating on a patient and leaving the post-op care to
general Ob/Gyns or surgeons is fraught with its own issues – a com-
plication on a “routine” case can lead to catastrophic consequences
when a surgeon with experience is not the person rounding on the
patient daily.”
A.2. Characteristics of both rural and centralized gynecologic oncology care
“[R]ural locations cannot support more than one doc and a solo gyn
onc is not an attractive proposition due to the emotional and physical
burden of what we do, let alone the issue of call and vacation cov-
erage.”
“We can't be all things to all people… It makes more economic sense
to have quality centers of excellence that maintain critical case ex-
perience and quality, rather than have gyn oncs travel to remote lo-
cations with poor medical support services.”
“The idea that the survival of gynecologic cancer patients is im-
proved simply because there was a Gyn Onc involved in their care is
wildly egotistical and blind to the broader implications of the results.
The survival was better because they left Smalltown and went to the Big
City, where the radiologist who read the CT scan was better, the pul-
monologist who followed them in the ICU was better, the staff was
better trained, the OR was better equipped, an experienced anesthe-
siologist took care of them… from top to bottom, the care was better.”
A.3. The need for coordination of centralized and local services
“I would respectfully submit from my experience that most invasive
gynecologic oncology cases could be evaluated, triaged (if needed) and
in most situations operated on in university academic hospitals or in
large community teaching hospitals (those with independent ob-gyn
residencies [for] example) where a real full service gynecologic on-
cology service can exist independently. Subsequent management should
include the gynecologic oncologist as the team leader for decision
making, whether primarily administering chemotherapy, collaborating
with gynecologic medical oncologists, or coordinating care with trusted
medical or radiation oncologists at further distances similar to high-risk
OB and trauma service triage systems… If perinatology and trauma
services conduct their care with distance referral routinely, why are we
unable to accomplish the same?”
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